Logo do repositório
 

Prolactin and zinc in dialysis patients

dc.contributor.authorCastro, AVB
dc.contributor.authorCaramori, J.
dc.contributor.authorBarretti, Pasqual [UNESP]
dc.contributor.authorBaptistelli, E. E.
dc.contributor.authorBrandao, A.
dc.contributor.authorBarim, E. M.
dc.contributor.authorPadovani, Carlos Roberto [UNESP]
dc.contributor.authorAragon, F. F.
dc.contributor.authorBrandao-Neto, J.
dc.contributor.institutionUniversidade Federal do Rio Grande do Norte (UFRN)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:24:37Z
dc.date.available2014-05-20T15:24:37Z
dc.date.issued2002-07-01
dc.description.abstractThe objectives of the present study were to investigate the frequencies of hyperprolactinemia and hypozincemia in patients undergoing hemodialysis (HD) or continuous ambulatory peritoneal dialysis (CAPD), the associations between blood levels of zinc (Zn2+) and hormones, and dietary zinc intake amount and its relation to zincemia. We studied 28 patients (14 HD and 14 CAPD) who had their blood levels of Zn2+, prolactin (PRL), parathyroid hormone (PTH), and gonadotropins (LH, FSH) evaluated. Thirteen patients had dietary nutrient amounts evaluated from a 3-d nutritional record. Hyperprolactinemia occurred in 29% patients (HD = CAPD), hypozincemia in 62% (20% HD and 42% CAPD), and low dietary Zn2+ intake in 90% of patients. No correlation among blood concentration of Zn2+ and PRL, PTH, LH, and FSH were observed in the two modalities of dialysis or between zincemia and Zn2+ ingestion. We concluded that the occurrence of hyperprolactinemia and hypozincemia were not related to dialysis modality and that zincemia did not reflect the observed low dietary intake of Zn2+.en
dc.description.affiliationUFRN, Ctr Ciências Saude, Unidade Endocrinol & Metab, BR-59010180 Natal, RN, Brazil
dc.description.affiliationUNESP, Fac Med, Unidade Endocrinol & Metab 1, São Paulo, Brazil
dc.description.affiliationUNESP, Fac Med, Unidade Dialise, São Paulo, Brazil
dc.description.affiliationUNESP, Inst Biociencias, Unidade Bioestatisitca, São Paulo, Brazil
dc.description.affiliationUnespUNESP, Fac Med, Unidade Endocrinol & Metab 1, São Paulo, Brazil
dc.description.affiliationUnespUNESP, Fac Med, Unidade Dialise, São Paulo, Brazil
dc.description.affiliationUnespUNESP, Inst Biociencias, Unidade Bioestatisitca, São Paulo, Brazil
dc.format.extent1-7
dc.identifierhttp://link.springer.com/article/10.1385%2FBTER%3A88%3A1%3A01
dc.identifier.citationBiological Trace Element Research. Totowa: Humana Press Inc., v. 88, n. 1, p. 1-7, 2002.
dc.identifier.issn0163-4984
dc.identifier.lattes5496411983893479
dc.identifier.orcid0000-0003-4979-4836
dc.identifier.urihttp://hdl.handle.net/11449/35194
dc.identifier.wosWOS:000176658500001
dc.language.isoeng
dc.publisherHumana Press Inc
dc.relation.ispartofBiological Trace Element Research
dc.relation.ispartofjcr2.361
dc.relation.ispartofsjr0,719
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectperitoneal dialysispt
dc.subjecthemodialysispt
dc.subjectprolactinpt
dc.subjectparathyroid hormonept
dc.subjectluteinizing hormonept
dc.subjectfollicule-stimulating hormonept
dc.subjectzincpt
dc.titleProlactin and zinc in dialysis patientsen
dc.typeArtigo
dcterms.licensehttp://www.springer.com/open+access/authors+rights
dcterms.rightsHolderHumana Press Inc
dspace.entity.typePublication
unesp.author.lattes5496411983893479[3]
unesp.author.lattes8727897080522289[7]
unesp.author.orcid0000-0003-4979-4836[3]
unesp.author.orcid0000-0002-7719-9682[7]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentClínica Médica - FMBpt

Arquivos

Licença do pacote

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: